|
業務類別
|
Biotechnology |
|
業務概覽
|
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions. |
| 公司地址
| 64 Sidney Street, Cambridge, MA, USA, 02139 |
| 電話號碼
| +1 617 588-5555 |
| 傳真號碼
| +1 617 588-5554 |
| 公司網頁
| https://www.vcel.com |
| 員工數量
| 398 |
| Mr. Dominick C. Colangelo |
Director, President and Chief Executive Officer |
-- |
26/02/2026 |
| Dr. Jonathan Mark Hopper |
Chief Medical Officer |
-- |
20/03/2025 |
| Mr. Michael Halpin |
Chief Operating Officer |
-- |
20/03/2025 |
| Mr. Sean C. Flynn |
Chief Legal Officer |
-- |
20/03/2025 |
| Mr. Joseph A. Mara |
Chief Financial Officer |
-- |
26/02/2026 |
| Ms. Karen Mahoney |
Chief Human Resources Officer |
-- |
20/03/2025 |
| Mr. Jonathan D. Siegal |
Vice President, Corporate Controller and Principal Accounting Officer |
-- |
26/02/2026 |
|
|
| Mr. Dominick C. Colangelo |
Director, President and Chief Executive Officer |
26/02/2026 |
| Dr. Paul K. Wotton,PhD |
Independent Director |
26/02/2026 |
| Dr. Robert L. Zerbe,M.D. |
Chairman of the Board |
26/02/2026 |
| Mr. Alan L. Rubino |
Independent Director |
26/02/2026 |
| Mr. Kevin F. Mclaughlin |
Independent Director |
26/02/2026 |
| Ms. Heidi M. Hagen |
Independent Director |
26/02/2026 |
| Ms. Lisa Wright |
Independent Director |
26/02/2026 |
|
|
|
|
